Amyris Biossance Launches in SEPHORA Canada Stores

EMERYVILLE, Calif., July 26, 2017 (GLOBE NEWSWIRE) -- Biossance™, the consumer beauty brand from Amyris, Inc. (NASDAQ: AMRS ), today announced that it will expand to SEPHORA in over 60 SEPHORA locations across Canada in January 2018, marking the beginning of international expansion for Biossance.

“Biossance products continue to exceed consumer expectations and deliver outstanding sales results for Amyris. Our commitment to sustainable ingredients and exceeding our consumer promise has led recently to Biossance achieving the best-selling eye gel as well as eye care product overall,” said Caroline Hadfield, Senior Vice President, Personal Care, at Amyris. “We are bringing great cosmetics products to consumers that are better for them and the planet. We are very pleased with having achieved another record quarter that has significantly exceeded our expectations and we are continuing to build on the momentum of our strong consumer demand.”

About SEPHORA

SEPHORA is a leader in global prestige retail, teaching and inspiring clients to play in a world of beauty. SEPHORA has earned its reputation with its expertise, innovation, and entrepreneurial spirit, and has been a pioneer in an unbiased approach to experiential retail since its debut in Paris in the early 1970’s. A year after its acquisition by luxury group LVMH Moët Hennessy Louis Vuitton in 1997, SEPHORA expanded to North America with a revolutionary store model that broke the beauty experience mold, and continues to evolve today. Now with more than 430 stores in the Americas—including US, Canada, Mexico, and Brazil—plus over 600 inside JCPenney, SEPHORA has become a leading international beauty destination with over 2,300 locations in 33 countries, plus an award-winning website, and intuitive mobile apps. At SEPHORA, whether beauty is an obsession or part of a routine, clients have the opportunity to play with 14,000 products from 200 carefully curated brands, featuring indie darlings, emerging favorites, trusted classics, and SEPHORA’s own, SEPHORA COLLECTION. In store, the client can access personalized recommendations at the Beauty Studio through interactive technology like the IQ systems, and garner a new look with makeovers, complimentary classes, hands-on events, and one-on-one consultations, all assisted by SEPHORA’s expertly trained beauty advisors who offer unbiased advice on every brand, in every beauty category. Online clients interact with an inclusive beauty community on the award-winning Beauty Board, interactive Beauty Talk, and through social media @SEPHORA. On their mobile device, clients can get inspired to try new looks through groundbreaking digital innovations, like SEPHORA Virtual Artist, and access one-of-a-kind, mobile-first experiences, like The Beauty Uncomplicator and Swipe It Shop It.  And SEPHORA Beauty Insider clients feed their beauty addiction with unique rewards and customized on-of-a-kind experiences. SEPHORA offers endless ways to explore beauty. With SEPHORA Stands, SEPHORA’s multi-pronged social impact program, the retailer continues to support its community and its people via SEPHORA Accelerate, Classes for Confidence and SEPHORA Stands Together. For the latest, visit SEPHORA.com

About Biossance Pioneering sustainable beauty through biotechnology, at Biossance we created a 100% plant-based squalane skincare line that is delivering the leading skin moisturizer while using only safe and sustainable ingredients. We formulate with a No Compromise™ approach, proudly blacklisting over 2,000 potentially harmful ingredients because the products you use make a difference for your health and the health of the planet. Biossance makes sure only the most trustworthy and powerful ingredients make the final cut. Because we believe and are committed to delivering both best performing and clean beauty products. The full Biossance skin care line can be found at www.Biossance.com and www.SEPHORA.com .

About Amyris Amyris is the integrated renewable products company that is enabling the world’s leading brands to achieve sustainable growth. Amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products. The company is delivering its No Compromise® products across a number of markets, including specialty and performance chemicals, flavors and fragrances, cosmetics ingredients, pharmaceuticals, and nutraceuticals. More information about the company is available at www.amyris.com.

Forward-Looking Statements This release contains forward-looking statements, and any statements other than statements of historical facts could be deemed to be forward-looking statements. These forward-looking statements include, among other things, statements regarding future events (such as expected expansion of Biossance in SEPHORA Canada locations and other international locations and anticipated Biossance sales results and consumer demand) that involve risks and uncertainties. These statements are based on management's current expectations and actual results and future events may differ materially due to risks and uncertainties, including risks related to manufacturing capacity at Amyris’s Brotas facility, delays or failures in development, production and commercialization of products, liquidity and ability to fund capital expenditures, Amyris’s reliance on third parties to achieve its goals, and other risks detailed in the “Risk Factors” section of Amyris’s quarterly report on Form 10-Q filed on May 15, 2017. Amyris disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events, or otherwise.

Amyris, the Amyris logo, and Biossance, and No Compromise are registered trademarks of Amyris, Inc. All other trademarks are the property of their respective owners. 

Contacts Elle Communications Media Contact: Megan Hey biossance@ellecomm.com +1 (855) 438-3553 Peter DeNardo Director, Investor Relations and Corporate Communications Amyris, Inc. +1 (510) 740-7481 investor@amyris.com pr@amyris.com